A new screening method for ATP-independent kinase inhibitors identifies repurposed anti-cancer drugs

EBioMedicine. 2018 Nov:37:21-22. doi: 10.1016/j.ebiom.2018.10.020. Epub 2018 Oct 24.

Authors

Michael Timaner¹, Yuval Shaked²

Affiliations

¹ Cell Biology and Cancer Science, Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Israel. Electronic address: [email protected].
² Cell Biology and Cancer Science, Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Israel. Electronic address: [email protected].

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents / pharmacology*
Drug Repositioning*
Drug Screening Assays, Antitumor* / methods
Enzyme Inhibitors / pharmacology*
Humans
Phosphotransferases / antagonists & inhibitors*
Protein Kinase Inhibitors / pharmacology

Substances

Antineoplastic Agents
Enzyme Inhibitors
Protein Kinase Inhibitors
Phosphotransferases